240 related articles for article (PubMed ID: 24967962)
1. IGFBP7 induces apoptosis of acute myeloid leukemia cells and synergizes with chemotherapy in suppression of leukemia cell survival.
Verhagen HJ; de Leeuw DC; Roemer MG; Denkers F; Pouwels W; Rutten A; Celie PH; Ossenkoppele GJ; Schuurhuis GJ; Smit L
Cell Death Dis; 2014 Jun; 5(6):e1300. PubMed ID: 24967962
[TBL] [Abstract][Full Text] [Related]
2. Emodin and Its Combination with Cytarabine Induce Apoptosis in Resistant Acute Myeloid Leukemia Cells in Vitro and in Vivo.
Chen Y; Gan D; Huang Q; Luo X; Lin D; Hu J
Cell Physiol Biochem; 2018; 48(5):2061-2073. PubMed ID: 30099447
[TBL] [Abstract][Full Text] [Related]
3. IGFBP7 is associated to prognosis and could suppress cell survival in cholangiocarcinoma.
Yue C; Yang M; Tian Q; Mo F; Peng J; Ma Y; Huang Y; Wang D; Wang Y; Hu Z
Artif Cells Nanomed Biotechnol; 2018; 46(sup2):817-825. PubMed ID: 29991293
[TBL] [Abstract][Full Text] [Related]
4. BAALC-associated gene expression profiles define IGFBP7 as a novel molecular marker in acute leukemia.
Heesch S; Schlee C; Neumann M; Stroux A; Kühnl A; Schwartz S; Haferlach T; Goekbuget N; Hoelzer D; Thiel E; Hofmann WK; Baldus CD
Leukemia; 2010 Aug; 24(8):1429-36. PubMed ID: 20535151
[TBL] [Abstract][Full Text] [Related]
5. IGFBP7 Induces Differentiation and Loss of Survival of Human Acute Myeloid Leukemia Stem Cells without Affecting Normal Hematopoiesis.
Verhagen HJMP; van Gils N; Martiañez T; van Rhenen A; Rutten A; Denkers F; de Leeuw DC; Smit MA; Tsui ML; de Vos Klootwijk LLE; Menezes RX; Çil M; Roemer MGM; Vermue E; Heukelom S; Zweegman S; Janssen JJWM; Ossenkoppele GJ; Schuurhuis GJ; Smit L
Cell Rep; 2018 Dec; 25(11):3021-3035.e5. PubMed ID: 30540936
[TBL] [Abstract][Full Text] [Related]
6. SNS-032 inhibits mTORC1/mTORC2 activity in acute myeloid leukemia cells and has synergistic activity with perifosine against Akt.
Meng H; Jin Y; Liu H; You L; Yang C; Yang X; Qian W
J Hematol Oncol; 2013 Feb; 6():18. PubMed ID: 23415012
[TBL] [Abstract][Full Text] [Related]
7. The simultaneous inhibition of the mTOR and MAPK pathways with Gnetin-C induces apoptosis in acute myeloid leukemia.
Espinoza JL; Elbadry MI; Taniwaki M; Harada K; Trung LQ; Nakagawa N; Takami A; Ishiyama K; Yamauchi T; Takenaka K; Nakao S
Cancer Lett; 2017 Aug; 400():127-136. PubMed ID: 28456658
[TBL] [Abstract][Full Text] [Related]
8. The insulin-like growth factor-I receptor kinase inhibitor NVP-AEW541 induces apoptosis in acute myeloid leukemia cells exhibiting autocrine insulin-like growth factor-I secretion.
Tazzari PL; Tabellini G; Bortul R; Papa V; Evangelisti C; Grafone T; Martinelli G; McCubrey JA; Martelli AM
Leukemia; 2007 May; 21(5):886-96. PubMed ID: 17361225
[TBL] [Abstract][Full Text] [Related]
9. Autocrine IGF-1/IGF-1R signaling is responsible for constitutive PI3K/Akt activation in acute myeloid leukemia: therapeutic value of neutralizing anti-IGF-1R antibody.
Chapuis N; Tamburini J; Cornillet-Lefebvre P; Gillot L; Bardet V; Willems L; Park S; Green AS; Ifrah N; Dreyfus F; Mayeux P; Lacombe C; Bouscary D
Haematologica; 2010 Mar; 95(3):415-23. PubMed ID: 20007139
[TBL] [Abstract][Full Text] [Related]
10. Autocrine insulin-like growth factor-I signaling promotes growth and survival of human acute myeloid leukemia cells via the phosphoinositide 3-kinase/Akt pathway.
Doepfner KT; Spertini O; Arcaro A
Leukemia; 2007 Sep; 21(9):1921-30. PubMed ID: 17581609
[TBL] [Abstract][Full Text] [Related]
11. CALCRL induces resistance to daunorubicin in acute myeloid leukemia cells through upregulation of XRCC5/TYK2/JAK1 pathway.
Tang S; Li S; Shi X; Sheng L; Mu Q; Wang Y; Zhu H; Xu K; Zhou M; Xu Z; Wu A; Ouyang G
Anticancer Drugs; 2024 Feb; 35(2):163-176. PubMed ID: 37948318
[TBL] [Abstract][Full Text] [Related]
12. Function and expression of insulin-like growth factor-binding protein 7 (IGFBP7) gene in childhood acute myeloid leukemia.
Hu S; Chen R; Man X; Feng X; Cen J; Gu W; He H; Li J; Chai Y; Chen Z
Pediatr Hematol Oncol; 2011 May; 28(4):279-87. PubMed ID: 21413833
[TBL] [Abstract][Full Text] [Related]
13. IGFBP7 activates retinoid acid-induced responses in acute myeloid leukemia stem and progenitor cells.
van Gils N; Verhagen HJMP; Rutten A; Menezes RX; Tsui ML; Vermue E; Dekens E; Brocco F; Denkers F; Kessler FL; Ossenkoppele GJ; Janssen JJWM; Smit L
Blood Adv; 2020 Dec; 4(24):6368-6383. PubMed ID: 33351133
[TBL] [Abstract][Full Text] [Related]
14. Interaction network of proteins associated with unfavorable prognosis in acute myeloid leukemia.
Rendon-Rodriguez JJ; Restrepo-Rodriguez LF; Rothlisberger S
Acta Biochim Pol; 2020 Dec; 67(4):475-483. PubMed ID: 33284559
[TBL] [Abstract][Full Text] [Related]
15. The insulin-like growth factor-1 receptor kinase inhibitor, NVP-ADW742, suppresses survival and resistance to chemotherapy in acute myeloid leukemia cells.
He Y; Zhang J; Zheng J; Du W; Xiao H; Liu W; Li X; Chen X; Yang L; Huang S
Oncol Res; 2010; 19(1):35-43. PubMed ID: 21141739
[TBL] [Abstract][Full Text] [Related]
16. SUMOylation of insulin-like growth factor 1 receptor, promotes proliferation in acute myeloid leukemia.
Zhang J; Huang FF; Wu DS; Li WJ; Zhan HE; Peng MY; Fang P; Cao PF; Zhang MM; Zeng H; Chen FP
Cancer Lett; 2015 Feb; 357(1):297-306. PubMed ID: 25448401
[TBL] [Abstract][Full Text] [Related]
17.
Zhou JD; Li XX; Zhang TJ; Xu ZJ; Zhang ZH; Gu Y; Wen XM; Zhang W; Ji RB; Deng ZQ; Lin J; Qian J
Aging (Albany NY); 2019 May; 11(10):3376-3391. PubMed ID: 31147526
[No Abstract] [Full Text] [Related]
18. MN1 overexpression induces acute myeloid leukemia in mice and predicts ATRA resistance in patients with AML.
Heuser M; Argiropoulos B; Kuchenbauer F; Yung E; Piper J; Fung S; Schlenk RF; Dohner K; Hinrichsen T; Rudolph C; Schambach A; Baum C; Schlegelberger B; Dohner H; Ganser A; Humphries RK
Blood; 2007 Sep; 110(5):1639-47. PubMed ID: 17494859
[TBL] [Abstract][Full Text] [Related]
19. IGFBP7 binds to the IGF-1 receptor and blocks its activation by insulin-like growth factors.
Evdokimova V; Tognon CE; Benatar T; Yang W; Krutikov K; Pollak M; Sorensen PH; Seth A
Sci Signal; 2012 Dec; 5(255):ra92. PubMed ID: 23250396
[TBL] [Abstract][Full Text] [Related]
20. Physiologic IGFBP7 levels prolong IGF1R activation in acute lymphoblastic leukemia.
Artico LL; Laranjeira ABA; Campos LW; Corrêa JR; Zenatti PP; Carvalheira JBC; Brambilla SR; Nowill AE; Brandalise SR; Yunes JA
Blood Adv; 2021 Sep; 5(18):3633-3646. PubMed ID: 34438446
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]